Sanctions can be levied against institutions that fail to disclose details of such misconduct, do not investigate allegations in a timely and fair manner, or take inappropriate action. In extreme circumstances sanctions could include suspending funding from an entire organization Image
When an organisation submits a grant application to @wellcometrust, they must confirm that the lead applicant, has not had an allegation of harassment upheld against them for which there is either a current formal disciplinary warning or an active sanction
wellcome.org/grant-funding/…
Bullying is any offensive, intimidating, malicious or insulting behaviour. It involves the misuse of power and can make the person being bullied feel vulnerable, upset, humiliated, undermined or threatened @wellcometrust
#ResearchCulture #ReImagineResearch
wellcome.org/grant-funding/…
Harassment is any unwanted physical, verbal or non-verbal conduct that has the purpose or effect of violating a person’s dignity or creating an intimidating, hostile, degrading, humiliating or offensive environment for them. It may be a single incident
“There is a serious problem with holding perpetrators of sexual misconduct, and the institutions that can enable their behaviour, to account,” says @DrEOChapman. If this policy is to work, it will require an overhaul of institutional disciplinary policies

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Krzysztof Potempa

Krzysztof Potempa Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BRAINCURES

Nov 22
Credibility in Neuroscience
Introducing @BritishNeuro & credibility in science
How statistical power influences expected reproducibility-Johan Carlin @johancarlin
Registered reports-Guillaume Rousselet @robustgar
Preregistration posters-Rik Henson @rikhens
Two cognitive biases that make it hard to do science well
-Confirmation bias: selective attention/memory
-Failure to understand probability
In response to what is referred to by some as the Reproducibility Crisis, the psychology community has been trialling various Open and Reproducible Science solutions. These initiatives are relatively new concepts to broader neuroscience @BritishNeuro
#RRI
bnacredibility.org.uk/academia
Read 7 tweets
Nov 21
#OfficeForTheWhistleblower
"It is important that people have a reliable route that they can take when they want to expose wrongdoing. An office for the whistleblower might be a potential route."
-@MaryRobinson01 Chair @AWhistleblowing
lordslibrary.parliament.uk/office-of-the-…
#Whistleblower #SDG16
Legislation is needed to clarify that whistleblowing should be viewed positively, like compliance, rather than negatively, like a form of corporate treachery that eventually unravels in costly, exhausting & embarrassing legal battles
-Georgina Halford-Hall
Whistleblowers need one place to go to find out where they stand, get support and advice, source the financial means to fight retaliation and get appropriate compensation for their damaged careers—for most #whistleblowers, whistleblowing is career ending
Read 4 tweets
Nov 21
#AtoZofdementia
Once amyloid starts to affect brain cells, it is thought to trigger a cascade of events, much like starting a row of falling dominoes. The brain’s immune cells become overactive and start to cause more harm than good. Blood flow can also be affected.
#AlzResearch
Your brain is the most complex thing in the universe. Billions of cells working together to control your emotions, memories, movement and speech. we can take steps to keep our brains healthy and reduce our risk of developing dementia later in life
#scicomm
A CT scan involves combining a series of X-rays taken from different angles of the head to produce images of a person’s brain to rule out conditions that cause similar symptoms to dementia and show structure changes that occur in diseases like Alzheimer’s
Read 14 tweets
Nov 20
Ines Greco @Simon_Lovestone lab have successfully demonstrated how text mining and in silico analysis can help to derive valid biomarker candidates for Alzheimer’s disease. However, their analysis covers mining various data sources available until 2006
…nslational-medicine.biomedcentral.com/articles/10.11…
Using the combination of HypothesisFinder, the ADO, and the Gene/Protein detection system in SCAIView, Malhotra et al @ApitiusHofmann extracted 289 speculative biomarker statements for mild, 101 for moderate and 182 for severe stages of Alzheimer’s disease
genomemedicine.biomedcentral.com/articles/10.11…
@ApitiusHofmann et al describe a panel of bioinformatics and modeling approaches that have been developed to identify candidate mechanisms of neurodegenerative diseases such as Alzheimer’s and Parkinson’s based on publicly available data and knowledge
mdpi.com/1422-0067/16/1…
Read 4 tweets
Nov 20
Most approved “priority” medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study from Nektarios Oraiopoulos @noraio1 at the University of Cambridge Judge Business School @CambridgeJBS and Don Drakeman @advent_ls
jbs.cam.ac.uk/insight/2020/b…
'The Risk of De-Risking Innovation: Optimal R&D Strategies in Ambiguous Environments' presents the first large-scale empirical validation of the theoretical literature predicting the superiority of decentralized parallel searches in ambiguous environments
journals.sagepub.com/doi/10.1177/00…
Biotech companies created 40% more US Food & Drug Administration @US_FDA-approved “priority” drugs than the entire pharmaceutical industry from 1998 through 2016 while spending less than half as much, says a study by @noraio1 and Don Drakeman @CambridgeJBS
jbs.cam.ac.uk/insight/2020/b…
Read 4 tweets
Nov 16
With increased longevity how do we tackle age-related disease?
How can we engage & empower patients in their healthcare journeys?
How do we increase access to breakthrough therapies for patients with rare diseases?
What's the future of AI in drug discovery
lifescienceintegrates.com/agenda/pharma-…
#PharmaIntegrates

An industry is forming around human longevity to treat age-related diseases like dementia and extend our lives. What does this mean for Pharma?

@jamesosh
@TinaWoods
Samantha Benham-Hermetz @AlzResearchUK
@MallucciLab
@RealAaronWeaver
#PharmaIntegrates session that explores advances in asthma treatments, latest research agenda and policies to overcome the burden of this disease with Jorge Bartolome-Areteia Therapeutics
@swoolnough @asthmalunguk
@SalmanRespdoc
@andyroddam @ukfuturehealth
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(